Dr. Alessandra Cesano M.D., Ph.D. Net Worth

Dr. Alessandra Cesano M.D., Ph.D. biography

Dr. Alessandra Cesano M.D., Ph.D. is the Chief Medical Officer at Essa Pharma Inc.

What is the salary of Dr D?

As the Chief Medical Officer of Essa Pharma Inc, the total compensation of Dr D at Essa Pharma Inc is $620,808. There are 2 executives at Essa Pharma Inc getting paid more, with Dr. David Ross Parkinson M.D. having the highest compensation of $829,556.

What's Dr D's mailing address?

Alessandra's mailing address filed with the SEC is C/O PUMA BIOTECHNOLOGY, INC., 10880 WILSHIRE BLVD., SUITE 2150, LOS ANGELES, CA, 90024.

Insiders trading at Essa Pharma Inc

Over the last 4 years, insiders at Essa Pharma Inc have traded over $924,311 worth of Essa Pharma Inc stock and bought 3,342,445 units worth $15,321,880 . The most active insiders traders include Growth N Vbb Biotech Ag Bio..., Franklin M Berger a Marella Thorell. On average, Essa Pharma Inc executives and independent directors trade stock every 57 days with the average trade being worth of $1,108,300. The most recent stock trade was executed by Peter Virsik on 9 September 2024, trading 694 units of EPIX stock currently worth $4,164.

What does Essa Pharma Inc do?

as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in our approach. we're firmly rooted in creative and open thinking, giving us an energy and approach that makes us a different kind of pharmaceutical company.

Essa Pharma Inc executives and stock owners

Essa Pharma Inc executives and other stock owners filed with the SEC include:

• Dr. David Ross Parkinson M.D.,
  Pres, CEO & Director
• Peter A. Virsik M.B.A., M.S.,
  Exec. VP & COO
• Dr. Alessandra Cesano M.D., Ph.D.,
  Chief Medical Officer
• David S. Wood C.M.A., CPA, M.B.A., MBA, CPA, CMA,
  Chief Financial Officer
• Neil Thapar,
  Exec.
• Loleta Harris,
  Exec.
• Leah Dimascio,
  Exec.
• Erin Rudsinski,
  Exec.
• Erica Osbourne,
  Exec.
• Chandtip Chandhasin,
  Exec.
• Scott Requadt,
  
• Philip W. Kantoff,
  
• Lauren Merendino,
  
• John Alexander Martin,
  
• Richard M Glickman,
  
• Gary Sollis,
  
• Marella Thorell,
  
• Sanford S Zweifach,
  
• Growth N Vbb Biotech Ag Bio...,
  
• David Ross Parkinson,
  Chief Executive Officer
• Peter Virsik,
  Chief Operating Officer
• Ari David Brettman,
  Director
• Franklin M Berger,
  
• David S. Wood,
  Chief Financial Officer